NCT00743470View on ClinicalTrials.gov

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2008

Conditions
HIVTuberculosis
Interventions
DRUG

lopinavir/ritonavir

lopinavir/ritonavir tablet; see arm for intervention description

DRUG

rifabutin

rifabutin capsule; see arms for intervention description

Trial Locations (1)

60085

Site Reference ID/Investigator# 11441, Waukegan

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00743470 - A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter